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Summary 
Patient and sample misidentification may cause significant
harm or discomfort to the patients, especially when incor-
rect data is used for performing specific healthcare activi-
ties. It is hence obvious that efficient and quality care can
only start from accurate patient identification. There are
many opportunities for misidentification in healthcare and
laboratory medicine, including homonymy, incorrect
patient registration, reliance on wrong patient data, mis-
takes in order entry, collection of biological specimens from
wrong patients, inappropriate sample labeling and inaccu-
rate entry or erroneous transmission of test results through
the laboratory information system. Many ongoing efforts
are made to prevent this important healthcare problem,
entailing streamlined strategies for identifying patients
throughout the healthcare industry by means of traditional
and innovative identifiers, as well as using technologic tools
that may enhance both the quality and efficiency of blood
tubes labeling. The aim of this article is to provide an
overview about the liability of identification errors in health-
care, thus providing a pragmatic approach for diverging
the so-called patient identification crisis.
Keywords: errors, patient safety, identification, misiden-
tification, laboratory medicine
Kratak sadr`aj
Pogre{no identifikovanje pacijenata i uzoraka mo`e naneti
zna~ajnu {tetu ili neprijatnost pacijentima, naro~ito ako se
neta~ni podaci koriste za izvo|enje specifi~nih zdravstvenih
aktivnosti. Otud je jasno da efikasna i kvalitetna nega mo`e
po~eti samo od ta~ne identifikacije pacijenata. Postoji
mno go prilika za pogre{nu identifikaciju u zdravstvenoj nezi
i la bo ratorijskoj medicini, uklju~uju}i homonimiju, neta~nu
re gi straciju pacijenta, oslanjanje na pogre{ne podatke o
pacijentu, gre{ke u uno{enju naloga, uzimanje biolo{kih
uzoraka od pogre{nih pacijenata, neodgovaraju}e obele ` a -
vanje uzoraka i neta~an unos ili pogre{no preno{enje rezul-
tata testova kroz laboratorijski informacioni sistem. Tre -
nutno se mnogo radi na otklanjanju ovih va`nih problema
uz zdravstvu, {to podrazumeva organizovane strategije za
identifikovanje pacijenata u ~itavoj zdravstvenoj industriji
putem tradicionalnih i inovativnih identifikatora, kao i po -
mo}u tehnolo{kih alatki koje mogu pobolj{ati kako kvalitet
tako i efikasnost ozna~avanja krvnih epruveta. Cilj ovog
rada je da se pru`i pregled o odgovornosti za gre{ke u iden-
tifikaciji u okviru zdravstvene nege, kako bi se omogu}io
pragmati~an pristup za re{avanje takozvane krize identifi -
kacije pacijenata. 
Klju~ne re~i: gre{ke, bezbednost pacijenta, identifikacija,
pogre{na identifikacija, laboratorijska medicina 
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Introduction
Due to several reasons, including largely sto-
chastic demand, limitation of resources, time pres-
sure and lack of or imperfect staff education, many
healthcare processes are inherently complicated,
multifaceted and thereby intrinsically vulnerable to
errors, which may ultimately jeopardize patient health
(1). According to the US Institute of Medicine (IOM),
the burden of preventable medical harm is dramati-
cally high, accounting for approximately 98.000
deaths each year in the country (2), thus exceeding
the number of deaths currently reported for firearms
homicides by the Federal Bureau of Investigation
(FBI) or the mortality burden caused by commercial
airline accidents worldwide (3).
Among the various medical errors, unquestion-
able evidence has been gathered that failure to cor-
rectly identify patients throughout the healthcare
industry may be associated with a number of unfavor-
able consequences, including direct patient harm,
medication errors, diagnostic errors (i.e., diagno ses/
test results attributed to the wrong patient), proce-
dures on wrong person or repetition, discharge of
infants to wrong families, as well as discomfort, stress
and anxiety for patients combined with stress, anxiety
and time pressure for healthcare staff (4). Notably,
treatment delays  are also unavoidable, since the cur-
rent guide lines mandate that diagnostic test results
plagued by a reasonable suspicion of mismatch
should not be delivered (5).
Unlike many other preventable causes of patient
harm, the epidemiologic liability of identification errors
in healthcare cannot be easily ascertained, and this is
mostly attributable to challenges or failures in detect-
ing identification errors across various healthcare set-
tings, the impressive burden of underreporting or
underestimation, fear of sanctioning, but also the fact
that not all identification errors translate into real
patient harm (i.e., near misses), thus being frequently
overlooked by the healthcare personnel. Of particular
concern is the issue of underreporting, especially
because patient harm due to identifi cation errors
should be mandatorily reported (as a »sentinel event«)
and the Working Group on »La boratory Errors and
Patient Safety« of the Inter na tional Federation of
Clinical Chemistry and Labo ratory Medicine (IFCC)
has included misidentification within the Priority 1
Quality Indicators of the preanalytical phase (6).
Between November 2003 and July 2005, the National
Reporting and Learning Service (NRLS) of the UK
National Patient Safety Agency has received as many
as 236 reports of patient safety incidents and near
misses relating to missing wristbands or wristbands
with incorrect information (7). As re gards the US, the
Joint Commission (JC) sentinel event statistics includes
130 cases of patient safety incidents attributable to
identification errors in 2015 (including transfusion
errors with wrong patient, wrong-site, wrong-proce-
dure), all of which had variable degrees of impact on
patient health (8). Henneman et al. carried out a pro -
spective simulated study in which health care workers
were asked to perform their daily activities (i.e., 28
nurses administering intravenous medi ca tions, 16 lab-
oratory technicians labeling blood spe ci mens and 17
emergency service associates applying identity bands)
using an eye-tracking device for patient recognition
(9). In 39% of all cases (39% nurses, 6% technicians,
71% emergency service associates) the staff per-
formed the assigned activity on the wrong patient, in
74% of all cases (87% nurses, 49% technicians) the
patient was not matched with the identity band and,
even more importantly, in 15% of all cases the error
was not recognized at the end of the procedure. 
Despite identification errors being conventional-
ly related to quality issues in blood transfusion (10)
and drug administration practices (11), diagnostics is
not seen as a safer arena, inasmuch as misidentifica-
tion is an important source of both medical imaging
(12), pathology (13) and laboratory (14) errors. As
specifically regards laboratory diagnostics, although
the identification error rate typically ranges between
1–2% of all mistakes throughout the total testing
process (15), the frequency has been reported to be
as high as 9% in urgent testing (16). Notably, a large
Q-Probes study endorsed by the College of American
Pathologists (CAP) (17) revealed that despite the fact
that a vast majority of identification errors (up to 86%)
could be identified before test verification, the
remaining were only detected after the test results
were released, thus yielding to a final estimation of 55
post-verification errors per 1 million billable tests. The
aggregate rate of adverse events out of the 6705
identification errors that occurred in the 120 different
laboratory services participating in the Q-Probes sur-
vey was 5.1%, encompassing significant patient
inconvenience with no change of treatment or patient
outcome in 72.8% of such cases, change in patient
treatment in 4.6% of cases and, finally, unfavorable
clinical impact in 22.6% of cases. Along with inaccu-
rate patient identification, specimen labeling errors
have been identified as one of the most challenging
tasks in laboratory diagnostics, occurring with a fre-
quency of approximately 1.3% (18). The major prob-
lems re ported are specimens mislabeled (30% of
cases), partially labeled (23% of cases), unlabeled
(22% of cases) or incompletely labeled (21% of all
cases), whereas illegible labels could be identified in
6% of cases. Whether or not these figures really
reflect the worldwide scenario, it seems reasonable to
conclude that healthcare is suffering from a patient
identity crisis, so that identification errors should now
be regarded as a public healthcare issue and one of
the leading concerns in laboratory diagnostics.
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How can this happen?
There are several circumstances throughout the
healthcare industry in which patient misidentification
may occur, many of which may be causes of diagnos-
tic errors and patient harm. These basically include
homonymy, incorrect patient registration, reliance on
wrong patient data, error in order entry (incorrect or
incomplete data entry), mistranscription of orders,
collection of biological specimens from the wrong
patient, inappropriate sample labeling and inaccurate
entry or transmission of test results in the laboratory
information system (LIS) (Table I). Interesting statistics
from the Harris County Hospital District (Texas, US)
(19) revealed that out of 3,428,925 patients includ-
ed in the Hospital District’s database, the number of
2 (or more) patients sharing the same last and first
names was as high as 249,213 (7.3%), whereas the
number of 2 (or more) patients sharing the same last
and first names and date of birth was up to 69,807
(2.0%), thus imposing a considerably high risk of
identity mismatch. Noteworthy, 2488 patients were
named Maria Garcia in the Hospital District, and 231
of these (9.3%) also shared the same date of birth.
The barriers for accurate patient 
identification
Despite the fact that the history of (laboratory)
medicine is plagued by several cases of identification
errors and many efforts have been driven to overcome
this important healthcare issue in the past decades,
technical and practical barriers remain. The main hur-
dles include process variation among healthcare
organizations and personnel, high expenditure associ-
ated with innovative and safer approaches, use of
technical solutions that may be unsuitable for specif-
ic care settings, integration of new technology inside
and across healthcare facilities, perception that the
relationship with a patient may be jeopardized by
repeated identity verification, increase of workload
and time spent for patient and sample identification,
the need for a cultural revolution as well as challenges
in achieving behavioral changes complying with the
available recommendations. 
Patient identification
There is general consensus that the healthcare
providers and health service organizations should
identify pertinent items approved for patient identifi-
cation to be used in their care settings. An accurate
patient identification should actually occur at patient
admission or registration; when matching patient
identity with diagnostics, care, therapy or other ser -
vices; whenever clinical handover, patient transfer or
patient documentation is generated; and within spe-
cific care settings different from those used through-
out the local facility. The approved patient identifiers
are usually items of information that can be used
when administering care services, and may basically
include patient name (first, possibly middle, and last
name), date and place of birth, gender, address, med-
ical record number, individual healthcare identifier
(IHI), identity card and/or passport and/or driving
license and/or other valid documents as for the local
legislation. 
The process of accurate patient identification
has originally been proposed by the JC many years
ago, and was then reiterated until recently within the
2016 National Patient Safety Goals (NPSG) (20).
More specifically, the NPSG.01.01.01 mandates that
at least two patient identifiers should be used when
collecting blood samples and other specimens for
clinical testing, or when providing other treatments
and procedures. Notably, the room number or physi-
cal location of the patient should not be used as iden-
tifiers, whereas containers used for blood and other
specimens should be labeled in the presence of the
patient. Rather understandably, no definitive advice is
given about the solutions to be used, wherein the
(human and economic) organization of the different
facilities differs widely, so that one solution working
Table I Causes of identification errors in medical laboratories.
•  Homonymy
•  Incorrect patient registration
•  Reliance on wrong patient data
•  Error in order entry (incorrect or incomplete data entry)
•  Order mistranscription 
•  Collection of biological specimens from the wrong patient
•  Inappropriate labeling of specimens
o  Specimens mislabeled
o  Specimens partially labeled
o  Specimens unlabeled
o  Illegible label
•  Inaccurate entry or transmission of test results in the Laboratory Information System
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for one healthcare organization may be unsuitable (or
unsustainable) for others. Unlike this approach, the
Clinical and Laboratory Standards Institute (CLSI) also
recognizes that patient identification is always crucial
(21), but suggests a specific sequence for patient
identification, entailing asking the patient to provide
the full name, address, identification number, and/or
birth date. The data should then be compared with
the information on the request form. Finally, a recent
document of the Working Group for Preanalytical
Phase (WG-PRE) of the European Federation of
Clinical Chemistry and Laboratory Medicine (EFLM)
recommends that a minimum of two (preferably
three) unique patient identifiers (one of which is the
full name of the patient) should be used for patient
identification (22).
Conventional or two-dimensional (2D) barcoded
wristbands are indeed the most used approach for
patient identification around the globe. The many
advantages and the potential drawbacks of this
approach have been comprehensively discussed else-
where (23). Alternative solutions, which became
available thanks to information technology (IT)
advances, are currently represented by radio-frequen-
cy identification (RFID) tags, infrared (IR)-based
patient tracking, wireless networks, patient smart
cards and biometric technologies. Several lines of evi-
dence now attest that most of these systems are high-
ly effective for reducing the burden of misidentifica-
tion throughout different healthcare settings (24–26).
However, each of these solutions, especially the most
widely applied (i.e., RFID tags and biometric tech-
nologies), has its own advantages and limitations.
The use of passive RFID devices implanted under the
skin of the upper arm and storing medical data has
been approved since 2004 by the US Food and Drug
Administration (FDA). As compared to traditional bar-
codes, RFID tags are capable of detecting patient
identity (and also localizing the patient within the
healthcare facility) from a much greater distance, can
be used without being positioned in line with a scan-
ner, can be read quickly, can be used as read/write
devices, are safer (e.g., data can be en crypted and
secured), carry large data capabilities (e.g., up to
2,000 bytes), can be used with minimal human con-
tribution and are substantially reusable. On the other
hand, the potential disadvantages of RFID tags
include necessary assembling into an expensive com-
puterized chip, problems of information capturing
through metals and/or liquids, collision of signals
from different readers, possible block of radiofre-
quency signal, limited battery life, impossibility to pro-
vide an absolutely unique patient identification. The
advantages of biometric tools are mainly represented
by the simple technology, less invasive approach,
rapidity, accuracy and minimal training required,
whereas the potential limitations include incremental
costs, challenging application on a large scale, con-
cerns about informed consent, privacy and secondary
uses, as well as changes in body shape or function
that may jeopardize system effici ency.
Sample identification
Unlike patient recognition, many recommenda-
tions have been published about appropriate identifi-
cation of biological specimens, sometimes providing
different advices. The reference procedure published
by the CLSI for collecting diagnostic blood specimens
by venipuncture (21) contains the instruction that
blood tubes should be labeled after filling and not
before. This is in clear contradiction with the recom-
mendations of the World Health Organization (WHO)
(27) and those of the Italian Society of Cli nical Bio -
chemistry and Laboratory Medicine (SIBioC) (28, 29),
both mandating that blood tubes should be labeled
before and not after filling. Notably, the WG-PRE of
the EFLM also recommends that patient and sample
identity should always be checked in the presence of
the patient, but also concludes that labeling the tubes
before or after blood collection should be based on a
local risk analysis of the phlebotomy process (22).
Although one of the authors of this article is an
active member of the WG-PRE of the EFLM, there are
several reasons prompting us to suggest that the
practice of labeling blood collection tubes after
venipuncture should be discouraged, and these most-
ly converge on the evidence that post-collection label-
ing of tubes carries a higher risk of identification
errors (30). By taking into account the available evi-
dence and the current expert recommendations, a
tentative approach to dealing with patient and sample
identification can hence be proposed, as shown in
Figure 1.
Patient identification
Use 2 (preferably 3) 
identifiers
• Patient name 
• Medical record number
• Individual Healthcare Identifier (IHI)
• Identity card
• Passport
• Driving license
• Other valid documents
Label blood tubes
before filling
Collect blood
Recheck patient ID 
and tube labels
Figure 1 Tentative approach to deal with patient and sam-
ple identification before blood collection.
What the future holds
Patient and/or sample identification errors are
significantly associated with harm or discomfort for
the patients, especially when incorrect data is used for
performing specific healthcare tasks or activities. It is
hence obvious that efficient and quality care can only
start with accurate patient identification, so that what-
ever technologic aid can be reliably proposed to limit
the risk of misidentification in healthcare should be
welcomed. Recent advances in mobile, digital identi-
fication, printing and labeling techniques have made
it easier to print patient-related documents close to
the patient and confirm the identity, thus improving
the efficiency and the safety of both patient identifica-
tion and tube labeling before venipuncture, while
con textually lowering the overall cost attributable to
blood collection (31). Innovative approaches are also
emerging for univocal patient identification, such as
human hand back skin texture detection (32), proba-
bilistic matching (33) or near field communication
(NFC). Interestingly, Hawker et al. recently developed
and validated an automated device based on four
cameras which photographs the outside of a sample
tube and then recognizes discrepancies between
patient identity in the LIS versus that on the blood
tube label by means of optical character recognition
(OCR) (34). The system was found to have a high
sensitivity for labeling errors (i.e., out of 742,977
total images that were passed, zero were mislabeled
by patient name or exhibited patient name spelling
discrepancies, yielding to 1.00 sensitivity; 95% CI
0.97–1.00), whereas the specificity was still modest
(only 121 true patient mislabels were identified in the
266,853 images classified as fails by the system,
yielding to 0.74 specificity; 95% CI 0.73–0.74). The
recently developed chip-size passive RFID Tag also
offers a locating capability and read range that are
comparable to an active tag, but in a form factor and
price that would allow to attach the tags to disposable
labels.
A final consideration can be made regarding
more active patient involvement in healthcare. In
accord with the joint recommendations of the WHO
and the JC (35), healthcare providers carry the pri-
mary responsibility of checking and verifying patient
identity, but patients should also actively participate in
the process and should receive education about the
importance of correct identification throughout the
healthcare industry.
Conclusions
The issue of diagnostic errors, which has only
received minor attention for decades, has now
become the focus of many important initiatives such
as the recent report on Improving Diagnosis in Health
Care (36). Considerable improvements in analytical
performances have indeed contributed to enhancing
both the quality and safety of laboratory diagnostics,
so leading the way to a redirection of further efforts
toward more vulnerable tasks of the total testing
process, especially in the pre-analytical phase, such
as patient and biological sample identification
(37–39). We hope that this article provides a useful
overview that will encourage good laboratory prac-
tices in this important aspect of testing that has not
received the attention it deserves in the past.
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